| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 2 buys and 5 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 26, 2017 | Crowley John F67 | Chairman &CEO | Buy | 1,395 | $14.36 | $20,032.20 | +0.4% | |
| Jul 13, 2017 | Perceptive Advisors LLC51 | 10% Owner | Buy | 1,500,000 | $12.25 | $18,375,000.00 | +9.2% | |
| Jun 19, 2017 | Barth Jay | Chief Medical Officer | Sale+OE | 30,000 | $10.00 | $300,000.00 | -31.9% | |
| May 19, 2017 | Do Hung | Chief Science Officer | Sell | 29,914 | $8.00 | $239,312.00 | -5.9% | |
| May 15, 2017 | Do Hung | Chief Science Officer | Sell | 29,914 | $8.00 | $239,312.00 | -5.6% | |
| Mar 2, 2017 | Campbell Bradley L66 | Chief Operating Officer | Sell | 49,050 | $8.00 | $392,400.00 | -27.8% | |
| Feb 7, 2017 | Do Hung | Chief Science Officer | Sell | 25,000 | $6.00 | $150,000.00 | -4.5% |